Skip to main content
Premium Trial:

Request an Annual Quote

Indiana University Wins $1.5M Cloud Computing Grant

NEW YORK (GenomeWeb News) – Indiana University has received a $1.5 million grant from the National Institutes of Health to develop a software infrastructure and use cloud computing for a variety of life sciences and genomics data applications, IU said today.

Scientists at the Pervasive Technology Institute Digital Science Center at Indiana University will use the funding in part to expand research begun with funding from the National Science Foundation, which was used to construct an experimental supercomputing network called FutureGrid.

Cloud computing techniques, which outsource computer infrastructure to create virtual supercomputers with enhanced computational powers, may be a useful technology for life sciences research that generates large volumes of data.

"This research is potentially path-breaking," Peter Cherbas, a professor of biology and director of the IU Center for Genomics and Bioinformatics, said in a statement.

"Contemporary DNA sequencing machines are churning out data at rates that would have been unimaginable to biologists just a few years ago,” he added. “To use these data — to turn data into some kind of understanding — will demand good tools for using the Cloud and those tools will impact genomics projects worldwide.”

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.